2023 Executive Summaries | 私立大學五星教授網

This two-day meeting will provide the latest strategies and guidelines for the treatment and management of COPD. Last year's event was sold out, so register ...

The GOLD 2023 report is a major revision of the GOLD 2022 report. Following systematic literature searches and double-blind review by the GOLD Science ...

guidelines.(254,255). Group E. ▻ A Cochrane systematic review and network meta-analysis comparing dual combination therapy versus mono long- acting ...

由 A Agustí 著作 · 2023 · 被引用 631 次 — The GOLD 2023 report recommends continuing treatments with long-acting bronchodilators during the exacerbation or to start these medications as soon as possible ...

Managing dyspnea in patients with advanced chronic obstructive pulmonary disease: a Canadian Thoracic Society clinical practice guideline. Can Respir J 2011; 18 ...

由 M Sharma 著作 · 2024 — GOLD 2023 has suggested limiting PFT to urgent or essential cases for diagnosis of COPD, especially during high COVID-19 prevalence. Reverse- ...

2023年12月27日 — New, more inclusive definitions of chronic obstructive pulmonary disease (COPD) and COPD exacerbations are included, along with important ...

由 A Agustí 著作 · 2023 · 被引用 5 次 — GOLD 2023 continues to recommend that follow-up treatment be based on two key treatable traits: dyspnoea and exacerbations (Fig. 4). Fig. 4: ...

This two-day meeting will provide the latest strategies and guidelines for the treatment and management of COPD. Last year's event was sold out, so register ...